Stockholm - Free Realtime Quote SEK

Nanologica AB (publ) (NICA.ST)

Compare
1.8850 -0.0400 (-2.08%)
As of 11:40:11 AM GMT+1. Market Open.
Loading Chart for NICA.ST
DELL
  • Previous Close 1.9250
  • Open 1.9500
  • Bid 1.8850 x --
  • Ask 1.9350 x --
  • Day's Range 1.8050 - 1.9500
  • 52 Week Range 1.6300 - 10.6500
  • Volume 4,951
  • Avg. Volume 112,084
  • Market Cap (intraday) 155.705M
  • Beta (5Y Monthly) 0.39
  • PE Ratio (TTM) --
  • EPS (TTM) -2.2400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.00

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide. The company operates through two segments, Drug Development and Chromatography. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA HPLC analytical columns. The company provides products for the analysis and purification of substances, with a focus on peptides and diabetes drugs. In addition, it is involved in the development of nanoporous amorphous particles (NAP), a platform technology for inhalation to give access to new or enhanced treatments for the patients with severe lung diseases. Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.

www.nanologica.com

16

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NICA.ST

View More

Performance Overview: NICA.ST

Trailing total returns as of 12/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NICA.ST
81.87%
OMX Stockholm 30 Index
2.95%

1-Year Return

NICA.ST
81.07%
OMX Stockholm 30 Index
3.87%

3-Year Return

NICA.ST
85.50%
OMX Stockholm 30 Index
5.75%

5-Year Return

NICA.ST
82.44%
OMX Stockholm 30 Index
37.56%

Compare To: NICA.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NICA.ST

View More

Valuation Measures

Annual
As of 12/20/2024
  • Market Cap

    159.01M

  • Enterprise Value

    158.91M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.80

  • Price/Book (mrq)

    7.34

  • Enterprise Value/Revenue

    20.12

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -30.72%

  • Return on Equity (ttm)

    -250.74%

  • Revenue (ttm)

    8.49M

  • Net Income Avi to Common (ttm)

    -76.29M

  • Diluted EPS (ttm)

    -2.2400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.08M

  • Total Debt/Equity (mrq)

    428.41%

  • Levered Free Cash Flow (ttm)

    -24.07M

Research Analysis: NICA.ST

View More

Company Insights: NICA.ST

Research Reports: NICA.ST

View More

People Also Watch